Schedule 13G ownership disclosure
Emerald Bioscience, Inc.
Security class unavailable · CUSIP: 29102Y101
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,480,000
- Percent of class
- 5.7900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-21-000048
- Form type
- SC 13G
- Filer
- Skye Bioscience, Inc.
- CIK
- CIK 1516551
- Filed
- Jan 07, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership